The Novel Role of Antibiotic Treatment in the Management of Cutaneous T-Cell Lymphoma (CTCL) Patients
- 12 May 2020
- journal article
- letter
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
- Vol. 24 (4) , 410-411
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphomaBlood, 2019
- Existing and Emerging Therapies for Cutaneous T-Cell LymphomaJournal of Cutaneous Medicine and Surgery, 2019
- Distribution and Clustering of Cutaneous T-Cell Lymphoma (CTCL) Cases in Canada During 1992 to 2010Journal of Cutaneous Medicine and Surgery, 2017
- Investigating potential exogenous tumor initiating and promoting factors for Cutaneous T-Cell Lymphomas (CTCL), a rare skin malignancyOncoImmunology, 2016
- Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxinsBlood, 2006